Skip To Main Content
Julie Zhou on Muck Rack

Julie Zhou

As seen in: MDPI, Flipboard, Science Magazine, Jotform Blog, Eater, Eater Twin Cities, BioRxiv, Cell Press, Odyssey, American Physiological Society and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Julie

Contact Julie, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

6 best practices for your growth marketing strategy

|
By Julie Zhou
| Jotform Blog
Tips for your growth marketing strategy Diversify your channels Pay attention to the whole funnel Repurpose your content Get your customers actively involved Measure and track everything A/B test your way to success Over the past decade, traditional marketing has given way to more data-driven, digital-based, and online marketing activities. This has created a new and massive industry called growth marketing.
Open in Who Shared Issue with article?

Intestinal stem cells enhance local mucosal immunity through apoptotic body phagocytosis

|
By Julie Zhou, Qiuhe Lu, Yujia Hu, Satoru Fujji
| BioRxiv
Abstract Modulation of immune tone at mucosal surfaces is critical to maintain homeostasis while facilitating the handling of emerging threats. One dynamic component of immune modulation is the phagocytosis and clearance of apoptotic bodies known as efferocytosis that inhibits inflammation by promoting its resolution. Here, we evaluated the effects of apoptotic body phagocytosis by intestinal epithelial stem and progenitor cells (ISCs).
Open in Who Shared Issue with article?

A host-adapted auxotrophic gut symbiont induces mucosal immunodeficiency

|
By Qiuhe Lu, J. G. Muir, Julie Zhou, Z. Chahine
| Science Magazine Verified
Editor’s summary The era of the microbiome has been opened by next-generation sequencing, and this tool has offered hints of multiple therapeutic targets for human diseases. However, it remains a challenge to pinpoint the cause of a clinical problem to any one species or consortium of microorganism. Using a screen to identify immunoglobulin A–degrading bacteria, Lu et al. have identified a previously unknown genus and species called Tomasiella immunophila (see the Perspective by Slack).
Open in Who Shared Issue with article?
See all 38 articles